Last month’s performance of 20.35% for iBio Inc (IBIO) is certainly impressive

On Friday, iBio Inc (AMEX: IBIO) opened lower -4.72% from the last session, before settling in for the closing price of $3.60. Price fluctuations for IBIO have ranged from $1.05 to $4.98 over the past 52 weeks.

A company in the Healthcare sector has dropped its sales by -18.92% annually for the last half of the decade. Company’s average yearly earnings per share was noted 60.55% at the time writing. With a float of $9.27 million, this company’s outstanding shares have now reached $9.87 million.

In an organization with 19 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 209.87%, operating margin of -4134.67%, and the pretax margin is -3795.73%.

iBio Inc (IBIO) Insider and Institutional Ownership

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of iBio Inc is 6.12%, while institutional ownership is 26.65%. The most recent insider transaction that took place on Jan 10 ’25, was worth 25,000. In this transaction Chief Financial Officer of this company bought 9,191 shares at a rate of $2.72, taking the stock ownership to the 11,139 shares. Before that another transaction happened on Jan 10 ’25, when Company’s insider bought 9,191 for $2.72, making the entire transaction worth $25,000. This insider now owns 18,316 shares in total.

iBio Inc (IBIO) Latest Financial update

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.34 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 60.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 45.01% during the next five years compared to 57.55% growth over the previous five years of trading.

iBio Inc (AMEX: IBIO) Trading Performance Indicators

Check out the current performance indicators for iBio Inc (IBIO). In the past quarter, the stock posted a quick ratio of 1.76. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 89.09.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.70, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach -1.38 in one year’s time.

Technical Analysis of iBio Inc (IBIO)

Let’s dig in a bit further. During the last 5-days, its volume was 0.26 million. That was inferior than the volume of 0.28 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 72.76%. Additionally, its Average True Range was 0.32.

During the past 100 days, iBio Inc’s (IBIO) raw stochastic average was set at 81.78%, which indicates a significant increase from 63.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 92.14% in the past 14 days, which was higher than the 80.75% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.81, while its 200-day Moving Average is $2.36. However, in the short run, iBio Inc’s stock first resistance to watch stands at $3.65. Second resistance stands at $3.88. The third major resistance level sits at $4.09. If the price goes on to break the first support level at $3.21, it is likely to go to the next support level at $3.00. The third support level lies at $2.77 if the price breaches the second support level.

iBio Inc (AMEX: IBIO) Key Stats

There are currently 9,875K shares outstanding in the company with a market cap of 33.85 million. Presently, the company’s annual sales total 230 K according to its annual income of -24,910 K. Last quarter, the company’s sales amounted to 180 K and its income totaled -7,780 K.